	Exosomal miRNA Sequencing and Bioinformatics in Breast Cancer: A Case-Control Study in Baise, China. J Vis Exp Pang G, Yuan S, Yang C, Su K, Ren B, Li M, Wei G, Liang L. PMID: 42825489 [PubMed - indexed for MEDLINE]
	Xiaoaiping Injection Combined with Chemotherapy Versus Chemotherapy Alone for Breast Cancer: A Systematic Review and Meta-Analysis. J Vis Exp Yue Z, Bo W, Yue-Kun W, Xiao-Chen C, Shi-Jia D, Hong P, Yang Y. PMID: 42825487 [PubMed - indexed for MEDLINE]
	Demographics, Tumor Biology and Treatment Outcomes of Male Breast Cancer Patients From a Tertiary Cancer Center in North India: A Real-World Study. Cureus Gupta D, Bapna A, Gupta AK, Patni S, Ledwani N, Chandorkar S. PMID: 42824934 [PubMed]
	Population-specific optimization of polygenic risk scores for breast cancer in East Asians. Genet Med Open Liu SH, Wang YC, Shieh YJ, Tan HF, Kao KJ, Hung CC, Hou MF, Huang CC, Lin CH, Feng AC, Chiou JF, Chen CH, Li LH, Taipei Medical University Hospital Consortium, Hsiao TH, Shao YJ. PMID: 42824742 [PubMed]
	Site-Specific Patterns of Distant Relapse on ^18F-FDG PET/Contrast-Enhanced CT According to Molecular Subtype in Breast Cancer: A Retrospective Cohort Study. Nucl Med Mol Imaging Chiaravalloti A, Vanni G, Verdesca L, Di Biagio D, Tavolozza M, Buonomo OC, Schillaci O. PMID: 42824600 [PubMed]
	Hematologic Toxicities and Determinants Among Patients With Breast Cancer Treated With Doxorubicin-Cyclophosphamide Followed by Paclitaxel in Northwest Ethiopia: A Retrospective Cohort Study. Health Sci Rep Tesfaye TC, Abebe RB, Mekonnen GB, Teferi ET, Bizuneh MM, Sendekie AK, Zerihun TE, Mussie DA, Kassaw AT, Wondm SA. PMID: 42824419 [PubMed]
	Biomarker-Driven Treatments for Ovarian Cancer: Moving Beyond HRD? Int J Womens Health Joseph L, Flynn M, Ledermann JA. PMID: 42824309 [PubMed]
	Surface-guided deep-inspiration breath-hold radiotherapy for left-sided breast cancer: a systematic review and meta-analysis of dosimetric outcomes and image-verified setup accuracy. Front Oncol Wu X, Wang H, Wu P, Zhang Y. PMID: 42824151 [PubMed]
	From HPV genotypes to cervical lesion burden: public health-relevant heterogeneity across 1.29 million screening records in Guangdong, China. Front Public Health Zhao Q, Yang C, Bu Q, Sun X, Hu G, He L, Wei Z, Wang G, Luo X, Gu J, Wu L, Luo X, Hong X. PMID: 42824128 [PubMed - indexed for MEDLINE]
	Squamous cell carcinoma arising from ovarian mature cystic teratoma with concurrent cervical high-risk HPV infection and low-grade squamous intraepithelial lesion: a case report. BMC Womens Health Zhao W, Sun Y, Ramadhany MMA, Wu R, Zhang Y. PMID: 42823697 [PubMed - indexed for MEDLINE]
	Universal versus Guideline-Directed Germline Testing in Breast Cancer: Incremental Diagnostic Yield in a Predominantly Black Population. Ann Surg Oncol Velazquez K, Jeng A, Roudakova K, Alberty-Oller JJ. PMID: 42823579 [PubMed - as supplied by publisher]
	Efficacy of everolimus and letrozole with or without ribociclib in recurrent endometrial cancer: a phase 2 randomized clinical trial. Nat Commun How JA, Westin SN, Pham M, Lawson B, Chen M, Tandon N, Yuan Y, Zhang R, Jazaeri AA, Sood AK, Onstad Grinsfelder M, Schmeler KM, Vining DJ, Fix SM, Dai Y, Bowen MB, Lu KH, Yates MS, Broaddus R, Soliman PT. PMID: 42823426 [PubMed - indexed for MEDLINE]
	Lower-Cost Nonsurgical Primary Prevention Strategies for Women at High Risk of Breast Cancer: A Scoping Review. Breast J Wen M, Zhao Y, He C. PMID: 42820352 [PubMed - indexed for MEDLINE]
	Antibody-drug conjugates in breast cancer: redefining targeted therapy. J Clin Invest Guo C, Ellisen LW. PMID: 42820303 [PubMed - indexed for MEDLINE]
	Toward targeted therapeutics for lobular breast cancer. J Clin Invest Fanucci KA, Bahnassy S, Roy AM, Sokolova A, Stover DG, Simpson PT, Riggins RB, Jeselsohn R. PMID: 42820289 [PubMed - indexed for MEDLINE]
	Expanding the therapeutic scope of PARP inhibitors in breast cancer: current indications and future directions. J Clin Invest Walmsley CS, Rodriguez A, Konstantinopoulos PA, Shapiro GI, Tolaney SM, Garber JE, Lynce F. PMID: 42820288 [PubMed - indexed for MEDLINE]
	Breast cancer immunogenicity as a spectrum: evolving concepts and therapeutic implications. J Clin Invest Kay J, Dixon-Douglas JR, Harris MA, van Geelen CT, Loi S. PMID: 42820285 [PubMed - indexed for MEDLINE]
	[Effects of phytoestrogens on prognosis and hormonal markers of breast cancer: A systematic review of randomized controlled trials]. Bull Cancer Poirier L, Diorio C. PMID: 42823214 [PubMed - as supplied by publisher]
	Predicting Chemoresistance in HER2-low Breast Cancer: Histologic Grade, MRI Non-mass Enhancement, and Clinical T Stage. Anticancer Res Fuse Y, Fushimi A, Nameki A, Kawase K, Nogi H. PMID: 42823184 [PubMed - indexed for MEDLINE]
	Impact of Resection Margin Width on Local Control and Prognostic Factors in HER2-enriched and Triple-negative Breast Cancer in the Modern Systemic Treatment Era. Anticancer Res Chang WI, Jang BS, Chang JH, Kim K, Shin KH. PMID: 42823150 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 335981

Page 1 of 16800



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy